Relationship between circulating serum osteoprotegerin and total receptor activator of nuclear κ-B ligand levels, triglycerides, and coronary calcification in postmenopausal women

Menopause

Volumn 21, Issue 7, 2014, Pages 702-710

  Poornima, Indu G ^a,b   MacKey, Rachel H ^c   Buhari, Alhaji M ^c   Cauley, Jane A ^c   Matthews, Karen A ^d   Kuller, Lewis H ^c  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Bone turnover; Coronary artery calcification; Osteoprotegerin; Postmenopausal women

Indexed keywords

OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TRIACYLGLYCEROL; BIOLOGICAL MARKER; OSTEOCLAST DIFFERENTIATION FACTOR;

ADULT; ARTICLE; BODY MASS; BONE TURNOVER; CARDIOVASCULAR RISK; CORONARY ARTERY CALCIFICATION; CORRELATION ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CALCINOSIS; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE;

BIOLOGICAL MARKERS; CALCINOSIS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MIDDLE AGED; OSTEOPROTEGERIN; POSTMENOPAUSE; PREDICTIVE VALUE OF TESTS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RISK FACTORS; TRIGLYCERIDES;

EID: 84903173235     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0000000000000127     Document Type: Article

References (43)

1. Kuller LH, Edmundowicz D. Imaging of coronary arteries aid in prevention of atherosclerosis and clinical coronary heart disease. Open Epidemiol J 2011;4:152-164.
2. Leopold JA. Vascular calcification. An age-old problem of old age. Circulation 2013;127:2380-2382.
3. Kuller LH, Matthews KA, Sutton-Tyrrell K, Edmundowicz D, Bunker CH. Coronary and aortic calcification among women 8 years after menopause and their premenopausal risk factors: the Healthy Women Study. Arterioscler Thromb Vasc Biol 1999;19:2189-2198. (Pubitemid 29422252)
4. Kuller LH, Lopez OL, Mackey RH, Rosano C, Becker JT, Newman AB. Coronary artery calcium and risk of death, dementia and disability in older 80+ year old individuals [Abstract 16511]. Circulation 2012;126: A16511.
5. Manson JE, Allison MA, Rossouw JE, et al. Estrogen therapy and coronary-artery calcification. N Engl J Med 2007;356:2591-2602. (Pubitemid 46961004)
6. Atsma F, Bartelink ML, Grobbee DE, van der Schouw YT. Postmeno-pausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause 2006;13:265-279.
7. Hu FB, Grodstein F, Hennekens CH, et al. Age at natural menopause and risk of cardiovascular disease. Arch Intern Med 1999;159:1061-1066. (Pubitemid 29230857)
8. Wildman RP, Colvin AB, Powell LH, et al. Associations of endogenous sex hormones with the vasculature in menopausal women: the Study of Women's Health Across the Nation (SWAN). Menopause 2008;15: 414-421. (Pubitemid 351656744)
9. de Kleijn MJ, van der Schouw YT, Verbeek AL, Peeters PH, Banga JD, van der Graaf Y. Endogenous estrogen exposure and cardiovascular mortality risk in postmenopausal women. Am J Epidemiol 2002;155: 339-345. (Pubitemid 34132052)
10. Sowers MR, Zheng H, Greendale GA, et al. Changes in bone resorption across the menopause transition: effects of reproductive hormones, body size, and ethnicity. J Clin Endocrinol Metab 2013;98:2854-2863.
11. Bakhireva LN, Barrett-Connor EL, Laughlin GA, Kritz-Silverstein D. Differences in association of bone mineral density with coronary calcification in men and women: the Rancho Bernado Study. Menopause 2005;12:691-698. (Pubitemid 41669121)
12. Kiel DP, Kauppila LI, Cupples LA, Hannan MT, O'Donnell CJ, Wilson PW. Bone loss and the progression of abdominal aortic calcification over a 25-year period: the Framingham Heart Study. Calcif Tissue Int 2001; 68:271-276. (Pubitemid 32565728)
13. Van Der Klift M, Pols HA, Hak AE, Witteman JC, Hofman A, de Laet CE. Bone mineral density and the risk of peripheral arterial disease. The Rotterdam Study. Calcif Tissue Int 2002;70:443-449. (Pubitemid 36929580)
14. Bild DE, Detrano R, Peterson D, et al. Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2005;111:1313-1320. (Pubitemid 40389097)
15. Jorgensen L, Joakimsen O, Rosvold Berntsen GK, Heuch I, Jacobsen BK. Low bone mineral density is related to echogenic carotid artery plaques: a population-based study. Am J Epidemiol 2004;160:549-556. (Pubitemid 39215631)
16. Dhore CR, Cleutjens JP, Lutgens E, et al. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2001;21:1998-2003. (Pubitemid 34219753)
17. Farhat GN, Cauley JA, Matthews KA, et al. Volumetric BMD and vascular calcification in middle-aged women: the Study of Women's Health Across the Nation. J Bone Miner Res 2006;21:1839-1846. (Pubitemid 44851559)
18. Farhat GN, Cauley JA. The link between osteoporosis and cardiovascular disease. Clin Cases Miner Bone Metab 2008;5:19-34. (Pubitemid 351847127)
19. Collin-Osdoby P. Regulation of vascular calcification by osteoclast regulatory factors RANK-L and osteoprotegerin. Circ Res 2004;95:1046-1057. (Pubitemid 39557891)
20. Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998;93: 165-176. (Pubitemid 28180851)
21. Bucay N, Sarosi I, Dunstan CR, et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998;12:1260-1268. (Pubitemid 28213402)
22. Omland T, Ueland T, Jansson AM, et al. Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes. J Am Coll Cardiol 2008;51:627-633. (Pubitemid 351193104)
23. Jensen JK, Ueland T, Atar D, et al. Osteoprotegerin concentrations and prognosis in acute ischaemic stroke. J Intern Med 2010;267:410-417.
24. Kiechl S, Schett G, Wenning G, et al. Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease. Circulation 2004; 109:2175-2180. (Pubitemid 38625393)
25. Vik A, Mathiesen EB, Johnsen SH, et al. Serum osteoprotegerin, sRANKL and carotid plaque formation and growth in a general populationVthe TromsL Study. J Thromb Haemost 2010;8:898-905.
26. Gadeau AP, Chaulet H, Daret D, Kockx M, Daniel-Lamaziere JM, Desgranges C. Time course of osteopontin, osteocalcin, and osteonectin accumulation and calcification after acute vessel wall injury. J Histochem Cytochem 2001;49:79-86. (Pubitemid 32012843)
27. Tyson KL, Reynolds JL, McNair R, et al. Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arterioscler Thromb Vasc Biol 2003;23: 489-494. (Pubitemid 36337227)
28. Fitzpatrick LA, Turner RT, Ritman ER. Endochondral bone formation in the heart: a possible mechanism of coronary calcification. Endocrinology 2003;144:2214-2219. (Pubitemid 36629869)
29. Kuller LH, Pettee Gabriel KK, Kinzel LS, et al. The Women On the Move through Activity and Nutrition (WOMAN) Study: final 48-month results. Obesity 2012;20:636-643.
30. Kuller LH, Kinzel LS, Pettee KK, et al. Lifestyle intervention and coronary heart disease risk factor changes over 18 months in postmenopausal women: the Women On the Move through Activity and Nutrition (WOMAN Study) clinical trial. J Womens Health 2006;15:962-974. (Pubitemid 44782267)
31. Mackey RH, Kuller LH, Sutton-Tyrrell K, Evans RW, Holubkov R, Matthews KA. Hormone therapy, lipoprotein subclasses and coronary calcium. The Healthy Women Study. Arch Intern Med 2005;165:510-515. (Pubitemid 40344381)
32. Lieb W, Gona P, Larson MG, et al. Biomarkers of the osteoprotegerin pathway: clinical correlates, subclinical disease, incident cardiovascular disease, and mortality. Arterioscler Thromb Vasc Biol 2010;30:1849-1854.
33. Reinhard H, Lajer M, Gall MA, et al. Osteoprotegerin and mortality in type 2 diabetic patients. Diabetes Care 2010;33:2561-2566.
34. Abedin M, Omland T, Ueland T, et al. Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study). Am J Cardiol 2007;99:513-518. (Pubitemid 46215559)
35. Ueland T, Wilson SG, Amirul Islam FM, et al. A cohort study of the effects of serum osteoprotegerin and osteoprotegerin gene polymorphisms on cardiovascular mortality in elderly women. Clin Endocrinol 2009;71: 828-833.
36. Jansson AM, Hartford M, Omland T, et al. Multimarker risk assessment including osteoprotegerin and CXCL16 in acute coronary syndromes. Arterioscler Thromb Vasc Biol 2012;32:3041-3049.
37. Roysland R, Bonaca MP, Omland T, et al. Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes. Heart 2012;98:786-791.
38. RLysland R, Masson S, Omland T, et al. Prognostic value of osteopro-tegerin in chronic heart failure: the GISSI-HF trial. Am Heart J 2010; 160:268-293.
39. Bezerra MC, Calomeni GD, Caparbo VF, Gebrim ES, Rocha MS, Pereira MR. Low bone density and low serum levels of soluble RANK ligand are associated with severe arterial calcification in patients with Takayasu arteritis. Rheumatology 2005;44:1503-1506. (Pubitemid 41742465)
40. Tsai JN, Uihlein A, Lee H, et al. Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomized trial. Lancet 2013;382:50-56.
41. Graham LS, Parhami F, Tintut Y, Kitchen CMR, Demer LL, Effros RB. Oxidized lipids enhance RANKL production by T lymphocytes: implications for lipid-induced bone loss. Clin Immunol 2009;133:265-275.
42. Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet 2010;375:1634-1639.
43. Samelson EJ, Miller PD, Christiansen C, et al. RANKL inhibition with denosumab does not influence 3-year progression of aortic calcification or incidence of adverse cardiovascular events in postmenopausal women with osteoporosis and high cardiovascular risk [published online ahead of print July 22, 2013]. J Bone Miner Res. doi: 10.1002/jbmr.2043.